"One-stop shops" aimed at speeding up cancer diagnosis are being introduced across England. The aim is to catch the disease earlier and prevent patients from being referred for several tests for different forms of the illness. Patients often face delays when they have non-specific symptoms. NHS England says this is a "step change" in the way people with suspected cancer are diagnosed and treated. The rapid diagnosis and then treatment of cancer can be vital in saving lives.
Each year 429,000 children and adolescents aged 0 to 19 years are expected to develop cancer. Five-year survival rates exceed 80% for the 45,000 children with cancer in high-income countries (HICs) but are less than 30% for the 384,000 children in lower-middle-income countries (LMICs). Improved survival rates in HICs have been achieved through multidisciplinary care and research, with treatment regimens using mostly generic medicines and optimized risk stratification. Children's outcomes in LMICs can be improved through global collaborative partnerships that help local leaders adapt effective treatments to local resources and clinical needs, as well as address common problems such as delayed diagnosis and treatment abandonment. Together, these approaches may bring within reach the global survival target recently set by the World Health Organization: 60% survival for all children with cancer by 2030. In recent years, 5-year survival rates for children with cancer (typically equating to cure) have risen to 80% in most high-income countries (HICs) (1–4). This progress reflects partly the optimized use of conventional therapies (e.g., cytotoxic drugs) through better risk stratification of patients.
They built a technology to speed up cardiac diagnosis and treatment. Their product combines equipment with artificial intelligence and medical expertise. For instance, when the wearable device tracks the heart rate of the patient, the information is sent to a centrally located hub where a qualified expert is available 24/7. The specialist interprets the electrocardiogram and sends the report through an SMS as well as through a message on Tricog's mobile app. This helps in faster diagnosis.
Cancer researchers are constantly advancing the technology that doctors use to screen for, detect, and treat all kinds of cancers, and the survivability prospects have greatly improved over the past few decades. Now, AI is giving scientists another tool in the fight against the disease, and one of the biggest names in the AI game is Google. In a new blog post, Google researchers explain that their AI known as LYNA -- short for Lymph Node Assistant -- has reached a level of sophistication that it can now tell the difference between cancer and non-cancer on slides with a stunning 99% accuracy. Google explains that, in a pair of recently-published research papers, the LYNA tool demonstrated incredible accuracy in determining whether breast cancer had spread to a patient's lymph nodes. Determining this is a major factor in deciding how a cancer patient might proceed, and can change the treatment options and approach that doctors take when handling a particular case.
CHICAGO - New research suggests that states that expanded Medicaid coverage under the Affordable Care Act eliminated racial differences in being able to quickly start on treatment after a diagnosis of advanced cancer. The law that is often called "Obamacare" let states expand Medicaid eligibility and offer subsidies to help people buy health insurance. Yale University researchers used electronic health records on 36,000 patients across the United States to gauge its impact. Before the law, 5 percent fewer blacks were starting treatment within a month of their cancer diagnoses. In states that expanded Medicaid, that difference went away.